tiprankstipranks
Xbrane Biopharma AB (SE:XBRANE)
:XBRANE
Sweden Market

Xbrane Biopharma AB (XBRANE) Technical Analysis

10 Followers

Summary of all the Indicators

Overall Consensus
Sell
8Bullish
3Neutral
11Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Xbrane Biopharma AB’s (XBRANE) Moving Averages Convergence Divergence (MACD) indicator is -0.31, suggesting Xbrane Biopharma AB is a Sell.
Xbrane Biopharma AB’s (XBRANE) 20-Day exponential moving average is 6.39, while Xbrane Biopharma AB’s (XBRANE) share price is kr10.37, making it a Buy.
Xbrane Biopharma AB’s (XBRANE) 50-Day exponential moving average is 7.73, while Xbrane Biopharma AB’s (XBRANE) share price is kr10.37, making it a Sell.

Xbrane Biopharma AB (XBRANE) Pivot Points

Apr 06, 2026, 06:26 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.39
5.69
6.19
6.49
6.99
7.29
7.79
Fibonacci
5.69
6.00
6.19
6.49
6.80
6.99
7.29
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Xbrane Biopharma AB (XBRANE) Moving Averages

Apr 06, 2026, 06:26 AM
Period
Simple
Exponential
MA5
6.41Buy
6.53Buy
MA10
6.19Buy
6.31Buy
MA20
6.03Buy
6.39Buy
MA50
7.96Sell
7.73Sell
MA100
9.13Sell
10.77Sell
MA200
19.62Sell
18.01Sell
Xbrane Biopharma AB’s (XBRANE) 10-Day exponential moving average is 6.31, while Xbrane Biopharma AB’s (XBRANE) share price is kr10.37, making it a Buy.
Xbrane Biopharma AB’s (XBRANE) 100-Day exponential moving average is 10.77, while Xbrane Biopharma AB’s (XBRANE) share price is kr10.37, making it a Sell.
Xbrane Biopharma AB’s (XBRANE) stock price is kr10.37 and Xbrane Biopharma AB’s (XBRANE) 50-day simple moving average is 7.96, creating a Sell signal.
Xbrane Biopharma AB’s (XBRANE) stock price is kr10.37 and Xbrane Biopharma AB’s (XBRANE) 100-day simple moving average is 9.13, creating a Sell signal.
Xbrane Biopharma AB’s (XBRANE) stock price is kr10.37 and Xbrane Biopharma AB’s (XBRANE) 200-day simple moving average is 19.62, creating a Sell signal.

Xbrane Biopharma AB (XBRANE) Technical Indicators

Apr 06, 2026, 06:26 AM
Name
Value
Implied Action
RSI (14)
56.47
Neutral
STOCH (9,6)
92.28
Sell
STOCHRSI (14)
92.28
Sell
MACD (12,26)
-0.31
Sell
ADX (14)
27.09
Neutral
Williams %R
-0.63
Sell
CCI (14)
299.22
Sell
ATR (14)
0.51
-
Ultimate Oscillator
60.81
Neutral
ROC
16.31
Buy
Xbrane Biopharma AB’s (XBRANE) Relative Strength Index (RSI) is 56.47, creating a Neutral signal.
Xbrane Biopharma AB’s (XBRANE) Trend Strength Indicator (ADX) is 27.09, creating a Neutral signal.
Xbrane Biopharma AB’s (XBRANE) Commodity Channel Index (CCI) is 299.22, creating a Sell signal.
Xbrane Biopharma AB’s (XBRANE) Price Rate of Change (ROC) is 16.31, creating a Buy signal.

FAQ

Is XBRANE a Buy, Hold, or Sell?
Based on XBRANE’s technical indicators, XBRANE is a Sell.
    What is XBRANE’s RSI (14)?
    XBRANE’s RSI (14) is 56.47, which suggests XBRANE is a Neutral.
      What is XBRANE’s MACD?
      XBRANE’s MACD is -0.31, which suggests XBRANE is a Sell.
        What is XBRANE’s 5-day moving average?
        XBRANE’s 5-day moving average is 6.41, which suggests XBRANE is a Buy.
          What is XBRANE’s 20-day moving average?
          XBRANE 20-day moving average is 6.03, which suggests XBRANE is a Buy.
            What is XBRANE’s 50-day moving average?
            XBRANE’s 50-day moving average is 7.96, which suggests XBRANE is a Sell.
              What is XBRANE’s 200-day moving average?
              XBRANE’s 200-day moving average is 19.62, which suggests XBRANE is a Sell.
                What is XBRANE’s Williams % R (14)?
                XBRANE’s Williams % R (14) is -0.63, which suggests XBRANE is a Sell.
                  What is XBRANE’s CCI (14)?
                  XBRANE’s CCI (14) is 299.22, which suggests XBRANE is a Sell.
                    What is the share price of Xbrane Biopharma AB?